Sangamo Therapeutics's Earnings Outlook

Sangamo Therapeutics (NASDAQ:SGMO) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Sangamo Therapeutics to report an earnings per share (EPS) of $-0.03.

Anticipation surrounds Sangamo Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Historical Earnings Performance

Last quarter the company missed EPS by $0.03, which was followed by a 13.46% drop in the share price the next day.

Here's a look at Sangamo Therapeutics's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

-0.15

-0.21

-0.26

-0.32

EPS Actual

-0.18

-0.27

-0.34

-0.59

Price Change %

-13.0%

7.000000000000001%

-1.0%

-22.0%

Sangamo Therapeutics Share Price Analysis

Shares of Sangamo Therapeutics were trading at $2.87 as of November 08. Over the last 52-week period, shares are up 763.58%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Views on Sangamo Therapeutics

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Sangamo Therapeutics.

The consensus rating for Sangamo Therapeutics is Buy, based on 4 analyst ratings. With an average one-year ...